Acetazolamide 125 MG Oral Tablet — RxCUI 197303
RxNorm drug concept · Semantic clinical drug
RxCUI 197303
Semantic clinical drug · SCD
● Current RxNorm concept 43 FDA products
56 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197303
Official nameAcetazolamide 125 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped43
Package NDCs mapped56
Reported Medicaid activity (SDUD)91,895 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetazolamide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is used as an add-on treatment, most commonly for glaucoma. Depending on the product, it is also used for swelling from heart failure, certain seizure disorders, and preventing...
- Tablets and capsules are taken by mouth, and the injection is given in a vein by a professional. Extended-release capsules for glaucoma are usually taken morning and evening. For m...
- Tingling in fingers or face, more urination, tiredness, nausea, appetite or taste changes, and drowsiness are among the reported effects. Mention them if they bother you.
- Call right away if you get a rash, blisters, fever, sore throat, unusual bruising, yellow skin or eyes, confusion, or swelling of the face. Acetazolamide is a sulfa-type drug, and...
🕸️ Concept Web — How Acetazolamide 125 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetazolamide 125 MG Oral Tablet
RxCUI 197303 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Acetazolamide
167IN
-
Acetazolamide
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetazolamide Oral Tablet
370525SCDF -
Acetazolamide Oral Product
1152847SCDG -
Acetazolamide Pill
1152848SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Acetazolamide Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetazolamide 125 MG
315271SCDC
-
Acetazolamide 125 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetazolamide 125 MG
SCDC · 315271 -
Acetazolamide Oral Tablet
SCDF · 370525 -
Acetazolamide Oral Product
SCDG · 1152847 -
Acetazolamide Pill
SCDG · 1152848
📦 FDA Products & Package NDCs
43 products · 56 package NDCs
56 package NDCs map to RxCUI 197303 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 10135-0830-01 | 100 TABLET in 1 BOTTLE (10135-830-01) | Acetazolamide | Marlex Pharmaceuticals, Inc. | 2026-02-01 |
| 10135-0831-01 | 100 TABLET in 1 BOTTLE (10135-831-01) | Acetazolamide | Marlex Pharmaceuticals, Inc. | 2026-02-01 |
| 23155-0287-01 | 100 TABLET in 1 BOTTLE (23155-287-01) | acetazolamide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-10-27 |
| 23155-0287-10 | 1000 TABLET in 1 BOTTLE (23155-287-10) | acetazolamide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-10-27 |
| 23155-0288-01 | 100 TABLET in 1 BOTTLE (23155-288-01) | acetazolamide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-10-27 |
| 23155-0288-10 | 1000 TABLET in 1 BOTTLE (23155-288-10) | acetazolamide | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2016-10-27 |
| 27241-0132-04 | 100 TABLET in 1 BOTTLE (27241-132-04) | Acetazolamide | Ajanta Pharma USA Inc. | 2023-09-11 |
| 27241-0133-04 | 100 TABLET in 1 BOTTLE (27241-133-04) | Acetazolamide | Ajanta Pharma USA Inc. | 2023-09-11 |
| 42291-0089-01 | 100 TABLET in 1 BOTTLE (42291-089-01) | acetazolamide | AvKARE | 2017-05-18 |
| 42291-0090-01 | 100 TABLET in 1 BOTTLE (42291-090-01) | acetazolamide | AvKARE | 2017-05-18 |
| 50090-5617-00 | 100 TABLET in 1 BOTTLE (50090-5617-0) | acetazolamide | A-S Medication Solutions | 2021-08-23 |
| 50090-5617-01 | 12 TABLET in 1 BOTTLE (50090-5617-1) | acetazolamide | A-S Medication Solutions | 2021-08-23 |
| 51655-0331-52 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-331-52) | acetazolamide | Northwind Health Company, LLC | 2023-03-28 |
| 52817-0200-00 | 1000 TABLET in 1 BOTTLE, PLASTIC (52817-200-00) | ACETAZOLAMIDE | TRUPHARMA, LLC | 2021-06-01 |
| 52817-0200-10 | 100 TABLET in 1 BOTTLE, PLASTIC (52817-200-10) | ACETAZOLAMIDE | TRUPHARMA, LLC | 2021-06-01 |
| 52817-0201-00 | 1000 TABLET in 1 BOTTLE, PLASTIC (52817-201-00) | ACETAZOLAMIDE | TRUPHARMA, LLC | 2021-06-01 |
| 52817-0201-10 | 100 TABLET in 1 BOTTLE, PLASTIC (52817-201-10) | ACETAZOLAMIDE | TRUPHARMA, LLC | 2021-06-01 |
| 55289-0720-06 | 6 TABLET in 1 BOTTLE, PLASTIC (55289-720-06) | Acetazolamide | PD-Rx Pharmaceuticals, Inc. | 2016-03-03 |
| 55289-0720-12 | 12 TABLET in 1 BOTTLE, PLASTIC (55289-720-12) | Acetazolamide | PD-Rx Pharmaceuticals, Inc. | 2016-03-03 |
| 59651-0905-01 | 100 TABLET in 1 BOTTLE (59651-905-01) | ACETAZOLAMIDE | Aurobindo Pharma Limited | 2025-05-30 |
| 59651-0906-01 | 100 TABLET in 1 BOTTLE (59651-906-01) | ACETAZOLAMIDE | Aurobindo Pharma Limited | 2025-05-30 |
| 62135-0607-12 | 120 TABLET in 1 BOTTLE (62135-607-12) | Acetazolamide | Chartwell RX, LLC | 2023-05-09 |
| 62135-0608-12 | 120 TABLET in 1 BOTTLE (62135-608-12) | Acetazolamide | Chartwell RX, LLC | 2023-05-09 |
| 63629-1194-01 | 100 TABLET in 1 BOTTLE (63629-1194-1) | Acetazolamide | Bryant Ranch Prepack | 2024-10-29 |
| 64380-0833-06 | 100 TABLET in 1 BOTTLE (64380-833-06) | Acetazolamide | Strides Pharma Science Limited | 2017-11-20 |
| 64380-0834-06 | 100 TABLET in 1 BOTTLE (64380-834-06) | Acetazolamide | Strides Pharma Science Limited | 2017-11-20 |
| 68071-3550-01 | 12 TABLET in 1 BOTTLE (68071-3550-1) | Acetazolamide | NuCare Pharmaceuticals,Inc. | 2023-12-01 |
| 68071-3632-01 | 100 TABLET in 1 BOTTLE (68071-3632-1) | acetaZOLAMIDE | NuCare Pharmaceuticals,Inc. | 2024-06-18 |
| 68071-3728-01 | 12 TABLET in 1 BOTTLE (68071-3728-1) | Acetazolamide | NuCare Pharmaceuticlas, Inc. | 2024-11-22 |
| 70710-1238-01 | 100 TABLET in 1 BOTTLE (70710-1238-1) | acetaZOLAMIDE | Zydus Pharmaceuticals (USA) Inc. | 2023-08-04 |
| 70710-1239-01 | 100 TABLET in 1 BOTTLE (70710-1239-1) | acetaZOLAMIDE | Zydus Pharmaceuticals (USA) Inc. | 2023-08-04 |
| 70756-0720-11 | 100 TABLET in 1 BOTTLE (70756-720-11) | Acetazolamide | Lifestar Pharma LLC | 2020-11-13 |
| 70756-0721-11 | 100 TABLET in 1 BOTTLE (70756-721-11) | Acetazolamide | Lifestar Pharma LLC | 2020-11-13 |
| 70756-0721-99 | 10 BLISTER PACK in 1 CARTON (70756-721-99) / 10 TABLET in 1... | Acetazolamide | Lifestar Pharma LLC | 2024-05-15 |
| 70771-1827-01 | 100 TABLET in 1 BOTTLE (70771-1827-1) | acetaZOLAMIDE | Zydus Lifesciences Limited | 2023-07-15 |
| 70771-1828-01 | 100 TABLET in 1 BOTTLE (70771-1828-1) | acetaZOLAMIDE | Zydus Lifesciences Limited | 2023-07-15 |
| 70954-0033-20 | 1000 TABLET in 1 BOTTLE (70954-033-20) | Acetazolamide | ANI Pharmaceuticals, Inc. | 2019-10-17 |
| 70954-0033-30 | 100 TABLET in 1 BOTTLE (70954-033-30) | Acetazolamide | ANI Pharmaceuticals, Inc. | 2019-10-17 |
| 70954-0034-20 | 1000 TABLET in 1 BOTTLE (70954-034-20) | Acetazolamide | ANI Pharmaceuticals, Inc. | 2019-10-17 |
| 70954-0034-30 | 100 TABLET in 1 BOTTLE (70954-034-30) | Acetazolamide | ANI Pharmaceuticals, Inc. | 2019-10-17 |
| 71205-0308-30 | 30 TABLET in 1 BOTTLE (71205-308-30) | Acetazolamide | Proficient Rx LP | 2019-09-01 |
| 71205-0308-60 | 60 TABLET in 1 BOTTLE (71205-308-60) | Acetazolamide | Proficient Rx LP | 2019-09-01 |
| 71205-0308-90 | 90 TABLET in 1 BOTTLE (71205-308-90) | Acetazolamide | Proficient Rx LP | 2019-09-01 |
| 71930-0008-12 | 100 TABLET in 1 BOTTLE (71930-008-12) | Acetazolamide | Eywa Pharma Inc | 2020-01-30 |
| 71930-0009-12 | 100 TABLET in 1 BOTTLE (71930-009-12) | Acetazolamide | Eywa Pharma Inc | 2020-01-30 |
| 72162-1978-01 | 100 TABLET in 1 BOTTLE (72162-1978-1) | Acetazolamide | Bryant Ranch Prepack | 2026-03-23 |
| 72578-0149-01 | 100 TABLET in 1 BOTTLE (72578-149-01) | acetaZOLAMIDE | Viona Pharmaceuticals Inc | 2023-07-15 |
| 72578-0150-01 | 100 TABLET in 1 BOTTLE (72578-150-01) | acetaZOLAMIDE | Viona Pharmaceuticals Inc | 2023-07-15 |
| 72789-0237-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-237-01) | Acetazolamide | PD-Rx Pharmaceuticals, Inc. | 2022-03-10 |
| 72789-0238-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-238-01) | Acetazolamide | PD-Rx Pharmaceuticals, Inc. | 2022-03-10 |
Observed labelers:
Aarkish Pharmaceuticals NJ Inc. (4) ·
ANI Pharmaceuticals, Inc. (4) ·
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (4) ·
PD-Rx Pharmaceuticals, Inc. (4) ·
TRUPHARMA, LLC (4) ·
Lifestar Pharma LLC (3)
· +17 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.